HIPAA, which turned 30 years old in August, merits new attention, particularly because it is and will be the primary statutory vehicle for... Read More
After $118,000 in fines for allowing unvaccinated students to attend Amish schools, the plaintiffs are pursuing a case that could reshape how... Read More
The United States economy meets the world at the port. Nearly everything on our store shelves, the food and goods our farmers and... Read More
Medicare was right to overhaul the way it pays for advanced wound care. Now it should judge that reform by how many wounds heal, how many... Read More
Something strange and potentially frightening is going on at a Russian laboratory in Siberia. One or more scientists have reportedly died,... Read More
The tragedy of the GLP-1 era will not be that these drugs failed. The tragedy will be if they succeed spectacularly. Read More
As more people turn to telehealth for GLP-1s, one type of pharmacy is coming under scrutiny. Read More
President Donald Trump is trying to best Sens. Bernie Sanders (I-VT) and Elizabeth Warren (D-MA) in demonizing pharmaceutical companies and... Read More
Americans prefer independent physician practices over corporate-owned hospitals by nearly a five-to-one margin. But despite patient... Read More
My previous two posts provided an overview of the District’s federal funding and compared it to the states. Today I turn to the largest... Read More
Afew weeks ago, I wrote about how President Trump’s decision to send rebates to some Obamacare customers represented sound policy. Read More
If rising health insurance costs are a concern, state policymakers should reconsider the coverage mandates that force people to buy more... Read More
The UK Covid-19 Inquiry has released the political chapters of its long-awaited report. After nearly three years, the conclusion is clear. Read More
Organizations are encouraged to support employees in developing good lifestyle habits to increase work engagement. Read More
I’ve seen clients start GLP-1 medications full of hope—and stop them feeling betrayed by their own biology. Read More
If the FDA policed only safety, not efficacy, the result would be more innovation at lower cost. Read More
The Alzheimer’s Policy Working Group is a 501(c)(3) organization that unites frontline clinicians from specialty and primary care to... Read More
On Thursday, January 22, the House Energy and Commerce Committee and the House Ways and Means Committee will each hold a hearing with some of... Read More
This is the fourth part of a series on the crisis in academic research and publishing. Read the first three parts here, here and here. By... Read More
Introduction In August, AHIP, the trade association for health insurance companies representing the industry’s top players, announced... Read More
This is a difficult moment for Roe v. Wade to have fallen.... Read More
If Congress and the administration do not plan and work together, the end of the old emergency will only mark the beginning of a new emergency.... Read More
The Affordable Care Act has faded into the political background since Republicans failed to repeal the entitlement in 2017, but ObamaCare still doesn't work as promised. The Biden Administration said this week that it will throw more money at one problem, and the result will be to hook more Americans on government subsidies. ... Read More
